24
Views
2
CrossRef citations to date
0
Altmetric
Research Article

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN THE TREATMENT OF NEONATES WITH NEUTROPENIA AND SEPSIS

, , , , , & show all
Pages 469-473 | Published online: 09 Jul 2009

References

  • Polin RA, St. Geme JW. Neonatal sepsis. Adv Pediatr Infect Dis. 1992;7:25–61.
  • Chanock SJ, Freifeld AG. Cytokines in the management of infectious complications in children with cancer. Int J Ped Hematol Oncol. 1995;2:173–183.
  • Kojima S. Cytokine treatment of aplastic anemia. Int J Pediatr Hematol Oncol 1995;2:135–141.
  • Cairo MS, Christensen R, Sender LS, et al. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birth weight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils. Blood. 1995; 86:2509–2915.
  • Cairo MS, Agostie J, Ellis R, et al. A randomized, double-blind, placebo-controlled trial of prophy-lactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates. J Pediatr. 1999;134:64–70.
  • Phillip AGS, Hewitt JR. Early diagnosis of neonatal sepsis. Pediatrics. 1980;65:1036–1041.
  • Rosenthal J, Cairo MS. Use of hematopoietic cytokines in combination with antibiotics in neonatal sepsis: a review of the role of adjunctive therapy in the management of neonatal sepsis. Int J Pediatr Hematol Oncol. 1995;2:477–487.
  • Cairo M, Suen Y Knoppel E, van de Ven C, Nguyen A, Sender L. Decreased stimulated GM-CSF production and GM-CSF gene expression but normal numbers of GM-CSF receptors in human term newborns compared with adults. Pediatr Res. 1991;30:362–367.
  • Lee S, Knoppel E, van de Ven C, Cairo M. Transcriptional rates of granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, interleukin-3 and macrophage colony-stimu-lating factor genes in activated cord vs. adult mononuclear cells: alteration in cytokine expression may be secondary to post-transcriptional instability. Pediatr Res. 1993;34: 560–564.
  • Gillan ER, Christensen RD, Suen y Ellis R, van de Ven C, Cairo MS. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia. Blood. 1994;84:1427–1433.
  • Costa JJ. Updates on cells and cytokines: the therapeutic use of hematopoietic growth factors. JA//ergy Clin Immunol. 1998;101:1–6.
  • Sreenan C, Osiovich H. Myeloid colony-stimulating factors: use in the newborn. Arch Pediatr Adolesc Med. 1999;153:984–988.
  • Rikonen P, Saarinen UM, Makipernaa A, et al. Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: a double blind placebo-controlled study in children. Pediatr Infect Disj 1994;13:197–202.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.